Drug Profile
PF 3882845
Alternative Names: PF-03882845; PF-3882845Latest Information Update: 12 Nov 2012
Price :
$50
*
At a glance
- Originator Pfizer
- Class Indazoles
- Mechanism of Action Mineralocorticoid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetic nephropathies; Type 2 diabetes mellitus
Most Recent Events
- 09 Aug 2012 Discontinued - Phase-I for Diabetic nephropathies in Singapore (PO)
- 09 Aug 2012 Discontinued - Phase-I for Diabetic nephropathies in USA (PO)
- 09 Aug 2012 Discontinued - Phase-I for Type-2 diabetes mellitus in Belgium (PO)